Of note, only approximately one-fourth of the AML blasts samples contributed significantly (p < 0.014, ANOVA on ranks/sample, samples compared to controls by Dunn’s test) to the higher levels of TFRC mRNA compared to non-leukemic CD34+ cells. This evidence concerns the gene TFRC and acute myeloid leukemia.